Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 10, 2013
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene
Monica Casucci, Serena Kimi Perna, Laura Falcone, et al.
Journal of Geriatric Oncology
|
October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Studies in Health Technology and Informatics
|
September 1, 2016
Key Data Elements in Myeloid Leukemia
Julian Varghese, Christian Holz, Phillip Neuhaus, et al.
International Journal of Antimicrobial Agents
|
April 10, 2021
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia
Daniela Clerici, Chiara Oltolini, Raffaella Greco, et al.
Blood
|
March 1, 2007
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri, Chiara Bonini, Sarah Marktel, et al.
Nature Communications
|
August 12, 2021
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia
Michela Consonni, Claudio Garavaglia, Andrea Grilli, et al.
Leukemia Research
|
February 8, 2016
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Lorenza Borin, et al.
American Journal of Hematology
|
July 31, 2018
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
Francesca Lorentino, Myriam Labopin, Massimo Bernardi, et al.
Diabetes
|
June 5, 2013
Autologous pancreatic islet transplantation in human bone marrow
Paola Maffi, Gianpaolo Balzano, Maurilio Ponzoni, et al.
Cancers
|
January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 10, 2013
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene
Monica Casucci, Serena Kimi Perna, Laura Falcone, et al.
Journal of Geriatric Oncology
|
October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Studies in Health Technology and Informatics
|
September 1, 2016
Key Data Elements in Myeloid Leukemia
Julian Varghese, Christian Holz, Phillip Neuhaus, et al.
International Journal of Antimicrobial Agents
|
April 10, 2021
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia
Daniela Clerici, Chiara Oltolini, Raffaella Greco, et al.
Blood
|
March 1, 2007
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri, Chiara Bonini, Sarah Marktel, et al.
Nature Communications
|
August 12, 2021
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia
Michela Consonni, Claudio Garavaglia, Andrea Grilli, et al.
Leukemia Research
|
February 8, 2016
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Lorenza Borin, et al.
American Journal of Hematology
|
July 31, 2018
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
Francesca Lorentino, Myriam Labopin, Massimo Bernardi, et al.
Diabetes
|
June 5, 2013
Autologous pancreatic islet transplantation in human bone marrow
Paola Maffi, Gianpaolo Balzano, Maurilio Ponzoni, et al.
Cancers
|
January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
Page
of 10